Reference
Kajihara Y, et al. Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. Scandinavian Journal of Gastroenterology 52: 238-241, No. 2, 2017. Available from: URL: http://doi.org/10.1080/00365521.2016.1250157 - Japan
Rights and permissions
About this article
Cite this article
Amoxicillin/clarithromycin/vonoprazan. Reactions Weekly 1649, 27 (2017). https://doi.org/10.1007/s40278-017-29306-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-29306-9